Cinctive Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,046
Closed -$3.77M 453
2025
Q4
$3.77M Buy
15,046
+3,560
+31% +$945K 0.2% 142
2025
Q3
$3.3M Buy
+11,486
New +$3.08M 0.16% 197
2025
Q2
Sell
-5,752
Closed -$1.34M 442
2025
Q1
$1.34M Sell
5,752
-19,339
-77% -$4.69M 0.1% 192
2024
Q4
$5.75M Buy
+25,091
New +$5.76M 0.29% 114
2024
Q1
Sell
-15,373
Closed -$3.49M 458
2023
Q4
$3.49M Buy
+15,373
New +$3.23M 0.23% 135
2022
Q2
Sell
-3,109
Closed -$704K 578
2022
Q1
$704K Sell
3,109
-18,499
-86% -$4.35M 0.03% 418
2021
Q4
$5.83M Buy
21,608
+17,856
+476% +$4.42M 0.26% 125
2021
Q3
$907K Sell
3,752
-19,294
-84% -$4.86M 0.04% 416
2021
Q2
$5.46M Buy
23,046
+11,790
+105% +$2.69M 0.26% 114
2021
Q1
$2.47M Sell
11,256
-7,338
-39% -$1.47M 0.15% 233
2020
Q4
$3.25M Sell
18,594
-21,455
-54% -$3.71M 0.27% 157
2020
Q3
$6.48M Buy
40,049
+16,181
+68% +$2.56M 0.57% 50
2020
Q2
$3.41M Buy
+23,868
New +$3.3M 0.39% 104

Other funds holding LH

Cinctive Capital Management's LH Position: Q1 2026 in Review

Cinctive Capital Management sold out of Labcorp (LH) in Q1 2026, closing a stake of 15,046 shares — an estimated $3.77M sold.

Cinctive Capital Management first reported a position in LH in Q2 2020 and held it in 13 quarters. The position peaked at $6.48M in Q3 2020. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Cinctive Capital Management reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 15,046 Labcorp shares in Q1 2026, an estimated $3.77M.
  • Cinctive Capital Management first reported a position in Labcorp in Q2 2020 and held it in 13 quarters.
  • Cinctive Capital Management's Labcorp position peaked at $6.48M in Q3 2020.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.